RNMT
Basic information
Region (hg38): 18:13726660-13764556
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNMT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 17 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 1 | 2 |
Variants in RNMT
This is a list of pathogenic ClinVar variants found in the RNMT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-13731521-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
18-13731552-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
18-13731579-C-T | not specified | Uncertain significance (Nov 20, 2023) | ||
18-13731609-A-C | not specified | Uncertain significance (Jan 26, 2022) | ||
18-13731662-G-A | not specified | Uncertain significance (Sep 14, 2023) | ||
18-13731683-G-A | not specified | Uncertain significance (Jul 20, 2022) | ||
18-13731702-T-G | not specified | Uncertain significance (Sep 01, 2021) | ||
18-13731836-A-G | not specified | Uncertain significance (Mar 25, 2022) | ||
18-13734511-A-G | Benign (Jul 18, 2018) | |||
18-13740200-A-C | not specified | Uncertain significance (Jun 30, 2023) | ||
18-13740206-A-T | not specified | Uncertain significance (Feb 08, 2023) | ||
18-13741577-G-A | not specified | Uncertain significance (Sep 22, 2022) | ||
18-13741681-T-C | not specified | Uncertain significance (Apr 22, 2022) | ||
18-13742558-G-C | not specified | Uncertain significance (Aug 02, 2022) | ||
18-13742595-A-G | not specified | Uncertain significance (Apr 20, 2023) | ||
18-13746263-T-C | not specified | Uncertain significance (Jan 04, 2022) | ||
18-13746271-A-C | not specified | Uncertain significance (Apr 15, 2024) | ||
18-13746277-C-T | Benign (Apr 07, 2018) | |||
18-13746289-T-G | not specified | Uncertain significance (Mar 25, 2024) | ||
18-13752326-C-T | not specified | Uncertain significance (Feb 07, 2023) | ||
18-13754134-A-G | Likely benign (Jul 26, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RNMT | protein_coding | protein_coding | ENST00000383314 | 10 | 37899 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000566 | 0.994 | 125722 | 0 | 21 | 125743 | 0.0000835 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.630 | 215 | 243 | 0.886 | 0.0000121 | 3176 |
Missense in Polyphen | 65 | 77.23 | 0.84165 | 1029 | ||
Synonymous | -0.165 | 81 | 79.1 | 1.02 | 0.00000371 | 809 |
Loss of Function | 2.45 | 11 | 23.9 | 0.460 | 0.00000120 | 340 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000679 | 0.0000679 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000179 | 0.000163 |
Finnish | 0.0000467 | 0.0000462 |
European (Non-Finnish) | 0.0000886 | 0.0000879 |
Middle Eastern | 0.000179 | 0.000163 |
South Asian | 0.000137 | 0.000131 |
Other | 0.000191 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalytic subunit of the mRNA-capping methyltransferase RNMT:RAMAC complex that methylates the N7 position of the added guanosine to the 5'-cap structure of mRNAs (PubMed:9790902, PubMed:9705270, PubMed:10347220, PubMed:11114884, PubMed:22099306, PubMed:27422871). Binds RNA containing 5'-terminal GpppC (PubMed:11114884). {ECO:0000269|PubMed:10347220, ECO:0000269|PubMed:11114884, ECO:0000269|PubMed:22099306, ECO:0000269|PubMed:27422871, ECO:0000269|PubMed:9705270, ECO:0000269|PubMed:9790902}.;
- Pathway
- mRNA surveillance pathway - Homo sapiens (human);mRNA Processing;Disease;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;Gene expression (Transcription);Transcription of the HIV genome;Late Phase of HIV Life Cycle;HIV Life Cycle;HIV Infection;RNA Pol II CTD phosphorylation and interaction with CE;RNA Polymerase II Transcription;Metabolism of RNA;Infectious disease;mRNA capping;mRNA Capping
(Consensus)
Recessive Scores
- pRec
- 0.111
Intolerance Scores
- loftool
- rvis_EVS
- 0.08
- rvis_percentile_EVS
- 60.09
Haploinsufficiency Scores
- pHI
- 0.408
- hipred
- Y
- hipred_score
- 0.671
- ghis
- 0.555
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.740
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rnmt
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- transcription by RNA polymerase II;7-methylguanosine mRNA capping;RNA 5'-cap (guanine-N7)-methylation;cellular response to leukemia inhibitory factor
- Cellular component
- fibrillar center;nucleus;nucleoplasm;mRNA cap binding complex;mRNA cap methyltransferase complex;receptor complex
- Molecular function
- RNA binding;mRNA (guanine-N7-)-methyltransferase activity;protein binding